The Immuno-Modulatory Effects of Inhibitor of Apoptosis Protein Antagonists in Cancer Immunotherapy
出版年份 2020 全文链接
标题
The Immuno-Modulatory Effects of Inhibitor of Apoptosis Protein Antagonists in Cancer Immunotherapy
作者
关键词
-
出版物
Cells
Volume 9, Issue 1, Pages 207
出版商
MDPI AG
发表日期
2020-01-16
DOI
10.3390/cells9010207
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Antagonism of IAPs enhances CAR T cell efficacy
- (2019) Jessica Michie et al. Cancer Immunology Research
- Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold
- (2019) David W. Vredevoogd et al. CELL
- SMAC mimetics promote NIK-dependent inhibition of CD4+ TH17 cell differentiation
- (2019) John Rizk et al. Science Signaling
- Natural Killer Cells Suppress T Cell-Associated Tumor Immune Evasion
- (2019) Andrew J. Freeman et al. Cell Reports
- A novel SMAC mimetic APG-1387 exhibits dual antitumor effect on HBV-positive hepatocellular carcinoma with high expression of cIAP2 by inducing apoptosis and enhancing innate anti-tumor immunity
- (2018) Wentao Pan et al. BIOCHEMICAL PHARMACOLOGY
- Interferon-γ and Smac mimetics synergize to induce apoptosis of lung cancer cells in a TNFα-independent manner
- (2018) Qin Hao et al. Cancer Cell International
- Analysis of response rate with ANTI PD1/PD-L1 monoclonal antibodies in advanced solid tumors: a meta-analysis of randomized clinical trials
- (2018) Alberto Carretero-González et al. Oncotarget
- IAPs Regulate Distinct Innate Immune Pathways to Co-ordinate the Response to Bacterial Peptidoglycans
- (2018) Che A. Stafford et al. Cell Reports
- Combination of IAP Antagonists and TNF-α-Armed Oncolytic Viruses Induce Tumor Vascular Shutdown and Tumor Regression
- (2018) Shawn T. Beug et al. Molecular Therapy-Oncolytics
- Oncolytic Viruses as Therapeutic Tools for Pediatric Brain Tumors
- (2018) Maider Varela-Guruceaga et al. Cancers
- Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
- (2018) Joy Hsu et al. JOURNAL OF CLINICAL INVESTIGATION
- Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
- (2018) Pascale André et al. CELL
- SMAC Mimetic Debio 1143 and Ablative Radiation Therapy Synergize to Enhance Antitumor Immunity against Lung Cancer
- (2018) Zhen Tao et al. CLINICAL CANCER RESEARCH
- PD-L1 Mediates Dysfunction in Activated PD-1+ NK Cells in Head and Neck Cancer Patients
- (2018) Fernando Concha-Benavente et al. Cancer Immunology Research
- The SMAC Mimetic APG-1387 Sensitizes Immune-Mediated Cell Apoptosis in Hepatocellular Carcinoma
- (2018) Zide Chen et al. Frontiers in Pharmacology
- Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy
- (2017) Paul A. Beavis et al. JOURNAL OF CLINICAL INVESTIGATION
- Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers
- (2017) Y Liu et al. ONCOGENE
- Selective replication of oncolytic virus M1 results in a bystander killing effect that is potentiated by Smac mimetics
- (2017) Jing Cai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Smac mimetics and oncolytic viruses synergize in driving anticancer T-cell responses through complementary mechanisms
- (2017) Dae-Sun Kim et al. Nature Communications
- Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma
- (2017) Shawn T. Beug et al. Nature Communications
- IAP Antagonists Enhance Cytokine Production from Mouse and Human iNKT Cells
- (2017) Eleanor Clancy-Thompson et al. Cancer Immunology Research
- The Smac Mimetic BV6 Improves NK Cell-Mediated Killing of Rhabdomyosarcoma Cells by Simultaneously Targeting Tumor and Effector Cells
- (2017) Kyra Fischer et al. Frontiers in Immunology
- Acute Sensitivity of Ph-like Acute Lymphoblastic Leukemia to the SMAC-Mimetic Birinapant
- (2016) J. Richmond et al. CANCER RESEARCH
- Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma
- (2016) Igor Puzanov et al. JOURNAL OF CLINICAL ONCOLOGY
- IAP antagonists induce anti-tumor immunity in multiple myeloma
- (2016) Marta Chesi et al. NATURE MEDICINE
- The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia
- (2016) Gabriela Brumatti et al. Science Translational Medicine
- Activation of concurrent apoptosis and necroptosis by SMAC mimetics for the treatment of refractory and relapsed ALL
- (2016) Scott McComb et al. Science Translational Medicine
- Oncolytic virus synergizes with Smac mimetic compounds to induce rhabdomyosarcoma cell death in a syngeneic murine model
- (2016) Christine C. Dobson et al. Oncotarget
- IAP antagonists sensitize murine osteosarcoma cells to killing by TNFα
- (2016) Tanmay M. Shekhar et al. Oncotarget
- Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or -refractory epithelial ovarian cancer
- (2015) Anne M. Noonan et al. CANCER
- IAP antagonization promotes inflammatory destruction of vascular endothelium
- (2015) A. Witt et al. EMBO REPORTS
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- A Phase I Study of the SMAC-Mimetic Birinapant in Adults with Refractory Solid Tumors or Lymphoma
- (2015) R. K. Amaravadi et al. MOLECULAR CANCER THERAPEUTICS
- Oncolytic viruses: a new class of immunotherapy drugs
- (2015) Howard L. Kaufman et al. NATURE REVIEWS DRUG DISCOVERY
- Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus
- (2015) Gregor Ebert et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The radiosensitizing activity of the SMAC-mimetic, Debio 1143, is TNFα-mediated in head and neck squamous cell carcinoma
- (2015) Oscar Matzinger et al. RADIOTHERAPY AND ONCOLOGY
- cIAPs and XIAP regulate myelopoiesis through cytokine production in an RIPK1- and RIPK3-dependent manner
- (2014) W. W.-L. Wong et al. BLOOD
- Synergistic interaction of Smac mimetic and IFNα to trigger apoptosis in acute myeloid leukemia cells
- (2014) Vanessa Bake et al. CANCER LETTERS
- Phase I Dose-Escalation Study of LCL161, an Oral Inhibitor of Apoptosis Proteins Inhibitor, in Patients With Advanced Solid Tumors
- (2014) Jeffrey R. Infante et al. JOURNAL OF CLINICAL ONCOLOGY
- Birinapant, a Smac-Mimetic with Improved Tolerability for the Treatment of Solid Tumors and Hematological Malignancies
- (2014) Stephen M. Condon et al. JOURNAL OF MEDICINAL CHEMISTRY
- Inhibitor of apoptosis proteins as therapeutic targets in multiple myeloma
- (2014) V Ramakrishnan et al. LEUKEMIA
- Smac mimetics and innate immune stimuli synergize to promote tumor death
- (2014) Shawn T Beug et al. NATURE BIOTECHNOLOGY
- Smac mimetics combined with innate immune stimuli create the perfect cytokine storm to kill tumor cells
- (2014) Shawn T Beug et al. OncoImmunology
- SMAC Mimetic BV6 Enables Sensitization of Resistant Tumor Cells but also Affects Cytokine-Induced Killer (CIK) Cells: A Potential Challenge for Combination Therapy
- (2014) Eva Rettinger et al. Frontiers in Pediatrics
- Regulation of ubiquitin transfer by XIAP, a dimeric RING E3 ligase
- (2013) Yoshio Nakatani et al. BIOCHEMICAL JOURNAL
- Induction of the DNA damage response by IAP inhibition triggers natural immunity via upregulation of NKG2D ligands in Hodgkin lymphoma in vitro
- (2013) Maike Sauer et al. BIOLOGICAL CHEMISTRY
- Linear ubiquitination-mediated NF- B regulation and its related disorders
- (2013) F. Tokunaga JOURNAL OF BIOCHEMISTRY
- Second mitochondria-derived activator of caspase (SMAC) mimetic potentiates tumor susceptibility toward natural killer cell-mediated killing
- (2013) Kerstin Brinkmann et al. LEUKEMIA & LYMPHOMA
- Two Coordinated Mechanisms Underlie Tumor Necrosis Factor Alpha-Induced Immediate and Delayed I B Kinase Activation
- (2013) K. Blackwell et al. MOLECULAR AND CELLULAR BIOLOGY
- c-IAP1 and c-IAP2 Redundancy Differs between T and B Cells
- (2013) Maria Letizia Giardino Torchia et al. PLoS One
- Inhibitor of Apoptosis (IAP) Proteins-Modulators of Cell Death and Inflammation
- (2013) J. Silke et al. Cold Spring Harbor Perspectives in Biology
- CLL cells are resistant to smac mimetics because of an inability to form a ripoptosome complex
- (2013) C Maas et al. Cell Death & Disease
- Smac mimetics induce inflammation and necrotic tumour cell death by modulating macrophage activity
- (2013) D Lecis et al. Cell Death & Disease
- Inhibitor of apoptosis protein (IAP) antagonists demonstrate divergent immunomodulatory properties in human immune subsets with implications for combination therapy
- (2012) Ashley J. Knights et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Proinflammatory Characteristics of SMAC/DIABLO-Induced Cell Death in Antitumor Therapy
- (2012) P. U. Emeagi et al. CANCER RESEARCH
- IAPs limit activation of RIP kinases by TNF receptor 1 during development
- (2012) Maryline Moulin et al. EMBO JOURNAL
- Inhibitor of Apoptosis Proteins (IAPs) and Their Antagonists Regulate Spontaneous and Tumor Necrosis Factor (TNF)-induced Proinflammatory Cytokine and Chemokine Production
- (2012) Conor J. Kearney et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Smac mimetic enables the anticancer action of BCG-stimulated neutrophils through TNF-α but not through TRAIL and FasL
- (2012) Goodwin Jinesh G. et al. JOURNAL OF LEUKOCYTE BIOLOGY
- LUBAC, a novel ubiquitin ligase for linear ubiquitination, is crucial for inflammation and immune responses
- (2012) Fuminori Tokunaga et al. MICROBES AND INFECTION
- The Ubiquitin Ligase XIAP Recruits LUBAC for NOD2 Signaling in Inflammation and Innate Immunity
- (2012) Rune Busk Damgaard et al. MOLECULAR CELL
- Targeting IAP proteins for therapeutic intervention in cancer
- (2012) Simone Fulda et al. NATURE REVIEWS DRUG DISCOVERY
- Cellular Inhibitors of Apoptosis Are Global Regulators of NF- B and MAPK Activation by Members of the TNF Family of Receptors
- (2012) E. Varfolomeev et al. Science Signaling
- Deletion of cIAP1 and cIAP2 in murine B lymphocytes constitutively activates cell survival pathways and inactivates the germinal center response
- (2011) S. Gardam et al. BLOOD
- IAPs: Guardians of RIPK1
- (2011) M Darding et al. CELL DEATH AND DIFFERENTIATION
- Smac Mimetics Activate the E3 Ligase Activity of cIAP1 Protein by Promoting RING Domain Dimerization
- (2011) Rebecca Feltham et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- IFN- Directly Promotes Programmed Cell Death-1 Transcription and Limits the Duration of T Cell-Mediated Immunity
- (2011) S. Terawaki et al. JOURNAL OF IMMUNOLOGY
- cIAPs Block Ripoptosome Formation, a RIP1/Caspase-8 Containing Intracellular Cell Death Complex Differentially Regulated by cFLIP Isoforms
- (2011) Maria Feoktistova et al. MOLECULAR CELL
- The Ripoptosome, a Signaling Platform that Assembles in Response to Genotoxic Stress and Loss of IAPs
- (2011) Tencho Tenev et al. MOLECULAR CELL
- Linear ubiquitination prevents inflammation and regulates immune signalling
- (2011) Björn Gerlach et al. NATURE
- Antagonists Induce a Conformational Change in cIAP1 That Promotes Autoubiquitination
- (2011) E. C. Dueber et al. SCIENCE
- c-IAP1 and UbcH5 promote K11-linked polyubiquitination of RIP1 in TNF signalling
- (2010) Jasmin N Dynek et al. EMBO JOURNAL
- Small-molecule pan-IAP antagonists: a patent review
- (2010) John A Flygare et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- IAP inhibitors enhance co-stimulation to promote tumor immunity
- (2010) Michael Dougan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Crystal Structures of the TRAF2: cIAP2 and the TRAF1: TRAF2: cIAP2 Complexes: Affinity, Specificity, and Regulation
- (2010) Chao Zheng et al. MOLECULAR CELL
- Non-Canonical NF-κB Activation and Abnormal B Cell Accumulation in Mice Expressing Ubiquitin Protein Ligase-Inactive c-IAP2
- (2010) Dietrich B. Conze et al. PLOS BIOLOGY
- RING Domain E3 Ubiquitin Ligases
- (2009) Raymond J. Deshaies et al. Annual Review of Biochemistry
- Smac mimetics as new cancer therapeutics
- (2009) Derrick J. Chen et al. ANTI-CANCER DRUGS
- RIPK1 is not essential for TNFR1-induced activation of NF-κB
- (2009) W W-L Wong et al. CELL DEATH AND DIFFERENTIATION
- TRAF2 Must Bind to Cellular Inhibitors of Apoptosis for Tumor Necrosis Factor (TNF) to Efficiently Activate NF-κB and to Prevent TNF-induced Apoptosis
- (2009) James E. Vince et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment
- (2009) Peter Geserick et al. JOURNAL OF CELL BIOLOGY
- Transfection with mRNA for CD19 specific chimeric antigen receptor restores NK cell mediated killing of CLL cells
- (2009) Laurent Boissel et al. LEUKEMIA RESEARCH
- Recruitment of the Linear Ubiquitin Chain Assembly Complex Stabilizes the TNF-R1 Signaling Complex and Is Required for TNF-Mediated Gene Induction
- (2009) Tobias L. Haas et al. MOLECULAR CELL
- cIAP1 and cIAP2 Facilitate Cancer Cell Survival by Functioning as E3 Ligases that Promote RIP1 Ubiquitination
- (2008) Mathieu J.M. Bertrand et al. MOLECULAR CELL
- Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas
- (2008) A. Kruschinski et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started